1.
2.
Therapeutic inertia in diabetes management is the failure to initiate or intensify pharmacological treatment when a patient's glycated hemoglobin (HbA1c) goals are not me [...]
2022 | Final project |
3.
This dissertation describes nocturnal sleep–wake patterns in adolescents undergoing chemotherapy and examines relationships among sleep, treatment‑related symptoms, and q [...]
2008 | Dissertation |
4.
The FDA has received millions of reports of adverse events over the last ten years. A clinician's ability to identify potential drug-drug interactions in routine practice [...]
2011 | Capstone |
5.
6.
A collection of patent medicines donated by John C. Brougher, M.D., in February 1976. The collection includes: 1) four clear glass ampules of "Prostigmin methylsulfate 1- [...]
1940 | Still image | Historical Collections and Archives |
7.
A collection of patent medicines donated by John C. Brougher, M.D., in February 1976. The collection includes: 1) four clear glass ampules of "Prostigmin methylsulfate 1- [...]
1940 | Still image | Historical Collections and Archives |
8.
Medical Museum Collection, Box 51
1920 | Still image | Historical Collections and Archives |
9.
Audio Visual Collection, Accession Number 2012.008
1957 | Still image | Historical Collections and Archives |
10.
The Bcr‑Abl tyrosine kinase drives chronic myeloid leukemia (CML) and is the target of imatinib therapy, which induces complete cytogenetic responses in most patients. Ho [...]
2007 | Dissertation |